Company Filing History:
2 out of 400 
1 out of 832,843 Years Active: 2016-2021
Title: Armin Huseinovic: Innovator in Charged Particle Therapy and Ion Implantation Systems
Introduction
Armin Huseinovic is a notable inventor based in Winchester, MA (US). He has made significant contributions to the fields of charged particle therapy and ion implantation systems. With a total of 3 patents to his name, Huseinovic's work is at the forefront of technological advancements in cancer treatment.
Latest Patents
Huseinovic's latest patents include the "Gantry charged particle nozzle system—rolling floor interface apparatus and method of use thereof." This invention features a segmented rolling floor apparatus designed for use in charged particle cancer therapy systems. The apparatus allows for the safe delivery of charged particles to a tumor while maintaining a walkable surface for patients.
Another significant patent is the "High throughput cooled ion implantation system and method." This system includes a process chamber and an ion implantation apparatus that implants ions into a workpiece. The design incorporates a load lock chamber and an isolation chamber to ensure efficient cooling and processing of the workpiece, enhancing the overall performance of the ion implantation process.
Career Highlights
Throughout his career, Huseinovic has worked with various companies, including Axcelis Technologies, Inc. His experience in the industry has allowed him to develop innovative solutions that address complex challenges in medical and industrial applications.
Collaborations
Huseinovic has collaborated with notable professionals in his field, including Joseph Ferrara and Brian Terry. These partnerships have contributed to the advancement of his inventions and the successful implementation of his technologies.
Conclusion
Armin Huseinovic is a distinguished inventor whose work in charged particle therapy and ion implantation systems has made a significant impact on technology and healthcare. His innovative patents and collaborations reflect his commitment to advancing these critical fields.